BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34334006)

  • 1. Systemic lupus erythematosus complicated with reversible posterior encephalopathy syndrome: a case report.
    Hao DL; Yang YL; Zhou LM; Liu QH; Liu R; Xu K; Zhang GL; Zhang LY
    J Int Med Res; 2021 Jul; 49(7):3000605211029766. PubMed ID: 34334006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case report].
    Zhang XH; Deng XR; Li F; Zhu Y; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1102-1107. PubMed ID: 30562790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus.
    Liu B; Zhang X; Zhang FC; Yao Y; Zhou RZ; Xin MM; Wang LQ
    BMC Neurol; 2012 Dec; 12():152. PubMed ID: 23217201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus.
    Ferreira TS; Reis F; Appenzeller S
    Lupus; 2016 Oct; 25(12):1369-76. PubMed ID: 27084028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis.
    Zhang YX; Liu JR; Ding MP; Huang J; Zhang M; Jansen O; Deuschl G; Eschenfelder CC
    Intern Med; 2008; 47(9):867-75. PubMed ID: 18451582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.
    Jung SM; Moon SJ; Kwok SK; Ju JH; Park KS; Park SH; Kim HY
    Lupus; 2013 Aug; 22(9):885-91. PubMed ID: 23846231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.
    Gatla N; Annapureddy N; Sequeira W; Jolly M
    J Clin Rheumatol; 2013 Sep; 19(6):334-40. PubMed ID: 23965484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus.
    Budhoo A; Mody GM
    Clin Rheumatol; 2015 Dec; 34(12):2127-34. PubMed ID: 26298534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.
    Tetsuka S; Nonaka H
    BMC Med Imaging; 2017 May; 17(1):35. PubMed ID: 28545408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central-variant posterior reversible encephalopathy syndrome in a young patient with systemic lupus erythematosus.
    Maier S; Monica C; Romaniuc A; Andone S; Bălaşa R
    Acta Neurol Belg; 2019 Jun; 119(2):269-271. PubMed ID: 30467758
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropsychiatric lupus with posterior reversible encephalopathy syndrome: a rare presentation.
    Islam R; Das S; Chattopadhyay S; Basu S
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34135075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A central nervous system lupus showing peculiar findings on cranial magnetic resonance imaging (MRI)].
    Takahashi T; Kokubun Y; Okuhata Y; Sawada S; Mizutani T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):409-16. PubMed ID: 14582367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus.
    Kur JK; Esdaile JM
    J Rheumatol; 2006 Nov; 33(11):2178-83. PubMed ID: 16960925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus following methylprednisolone: report of two cases.
    Chennareddy S; Adapa R; Kishore BK; Rajasekhar L
    Int J Rheum Dis; 2013 Dec; 16(6):786-8. PubMed ID: 24131800
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study.
    Damrongpipatkul U; Oranratanachai K; Kasitanon N; Wuttiplakorn S; Louthrenoo W
    Clin Rheumatol; 2018 Mar; 37(3):691-702. PubMed ID: 29103182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging changes and clinical features of reversible posterior leukoencephalopathy syndrome.
    Cui X; Jin H; Fang Y; Yang S; Xing W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1673-1682. PubMed ID: 36748377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome and intracranial vasculopathy.
    Chen HA; Lin YJ; Chen PC; Chen TY; Lin KC; Cheng HH
    Int J Rheum Dis; 2010 Oct; 13(4):e79-82. PubMed ID: 21199460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome as an initial manifestation of systemic lupus erythematosus.
    Ayas ÖZ; Öcal RÖ; Gundogdu AA
    Ideggyogy Sz; 2017 Nov; 70(11-12):425-427. PubMed ID: 29870651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare entity in ED: posterior reversible encephalopathy syndrome.
    Yetkin MF; Salt O; Durukan P; Erdogan FF; Ozkan S
    Am J Emerg Med; 2012 Nov; 30(9):2099.e1-3. PubMed ID: 22560100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy.
    Xie L
    J Oncol Pharm Pract; 2023 Sep; 29(6):1503-1509. PubMed ID: 37218162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.